Marin: Eighth Participant Enrolled; Brain Imaging Data Collection Starts

On March 7, 2016, the eighth participant was enrolled in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with a life-threatening illness. On April 3, investigators announced that the first participant has been scanned in an additional fMRI brain imaging study of the physiological correlates of MDMA-assisted psychotherapy in subjects with anxiety associated with life-threatening illness. The brain imaging sub-study is a collaboration between the MAPS-sponsored study and Michael Silver, Ph.D., at the Helen Wills Neuroscience Institute at the University of California, Berkeley.